Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of GPD-1116 on late-phase asthmatic response to allergen challenge
2008-005813-23Phase 2Completed
- Sponsor
- ASKA Pharmaceutical Holdings Co., Ltd.
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in allergic asthma comparing GPD-1116 with Placebo (2 arms). Primary endpoint: Late-phase asthmatic response to allergen challenge. Started Oct 2008; status: completed.
02
Drugs
GPD-1116
03
Conditions
allergic asthma
Beyond the preview
Go deeper on 2008-005813-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005813-23.